Clinical observation of raltitrexed combination with irinotecan versus FOLFIRI regimen as second-line treatment for advanced colorectal cancer

XIE Dacheng; LI Ning; WANG Jingjue; JIANG Weihua; WAGN Liwei; ZHOU Fei

doi:10.3969/j.issn.1009-0460.2013.02.011

Home>Articles>Clinical observation of raltitrexed combination with irinotecan versus FOLFIRI regimen as second-line treatment for advanced colorectal cancer

DOI: 10.3969/j.issn.1009-0460.2013.02.011

Clinical observation of raltitrexed combination with irinotecan versus FOLFIRI regimen as second-line treatment for advanced colorectal cancer

XIE Dacheng

LI Ning

WANG Jingjue

JIANG Weihua

WAGN Liwei

ZHOU Fei

Machine-generated Keywords：

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 140-143 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2013,18(2)